Medi Assist Ser.
Medi Assist Ser. Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters. The company expects to improve core EBITDA margins over the next 2 to 3 quarters through disciplined execution and integration of Paramount (Page 18).
From Medi Assist Ser.'s Q3 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters.
- Retail premiums are expected to recover and grow post a 2-3 quarter typical reallocation cycle in PSU portfolios.
- Expansion of technology-led revenue streams, especially from SaaS products like MAtrix and AI-driven solutions such as MAven Guard, with tech revenues growing 81.5% over 9 months and now making ~2.5% of total revenue.
- Increasing market penetration with new insurer partnerships, both in India and internationally, including travel and private medical insurance segments.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Medi Assist Ser. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has become debt-free, providing capital availability to judiciously deploy in services to enhance customer experiences.
- There is a strong focus on technology deployments, particularly on expanding the tech SaaS revenue model (e.g., MAtrix platform, MAven Guard, and other AI capabilities).
- Investments are underway in digital infrastructure and tech platforms, including the technology transformation related to Star Health integration.
- AI-led products and technology-driven services, such as fraud, waste and abuse detection (MAven Guard) and cashless experience improvement (Raksha Prime), are areas of strategic investment.
2 more points management made on capital expenditure plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Medi Assist Ser. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Medi Assist Ser. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹242 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medi Assist Ser.'s management said in earlier quarters
Others in Insurance this season
- New India Assurance Company Ltd (Q3 FY26)
Market share is stable or growing in key segments: Fire (17-18%), Marine (18%), and Health/PA (~16.44%). Key concall takeaways from New India Assurance Company…
- Canara HSBC Life Insurance Company Ltd (Q3 FY26)
Annuity business AP grew 34% year-on-year, with focus on deferred annuity for profitable growth. Key concall takeaways from Canara HSBC Life Insurance Company…
- Niva Bupa Health (Q3 FY26)
Overall growth in Q3 was 31%, and 26% for the first 9 months, indicating strong upward momentum. Key concall takeaways from Niva Bupa Health Insurance Company…
- Life Insurance Corporation of India (Q3 FY26)
Bancassurance and alternate channels have shown strong premium growth (40%+ for banks and 126%+ for alternate channels), with efforts to further enhance these…
Frequently Asked Questions
What were Medi Assist Ser. Q3 FY26 results?
Growth expected from ongoing migration of insurer volumes to the MAtrix platform, with full volume ramp-up anticipated in the next 2-3 quarters. The company expects to improve core EBITDA margins over the next 2 to 3 quarters through disciplined execution and integration of Paramount (Page 18).
What is Medi Assist Ser. share price analysis?
Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 27.3 with a market cap of ₹2,695 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medi Assist Ser. planning capital expenditure?
The company has become debt-free, providing capital availability to judiciously deploy in services to enhance customer experiences.
Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.